4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001209191-22-042842
Options or other derivatives
- Chief Financial Officer acquired 492,500 shares (grant or award)
- Chief Financial Officer returned 492,500 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Piscitelli Dominic Chief Financial Officer | 2022-07-20 | Returned to the company · Stock Option (right to buy) | −207,500 | 0 | D | ||
| Piscitelli Dominic Chief Financial Officer | 2022-07-20 | Returned to the company · Stock Option (right to buy) | −86,250 | 0 | D | ||
| Piscitelli Dominic Chief Financial Officer | 2022-07-20 | Returned to the company · Stock Option (right to buy) | −90,000 | 0 | D | ||
| Piscitelli Dominic Chief Financial Officer | 2022-07-20 | Returned to the company · Stock Option (right to buy) | −108,750 | 0 | D | ||
| Piscitelli Dominic Chief Financial Officer | 2022-07-20 | Grant or award · Stock Option (right to buy) | +207,500 | 207,500 | D | ||
| Piscitelli Dominic Chief Financial Officer | 2022-07-20 | Grant or award · Stock Option (right to buy) | +86,250 | 86,250 | D | ||
| Piscitelli Dominic Chief Financial Officer | 2022-07-20 | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | D | ||
| Piscitelli Dominic Chief Financial Officer | 2022-07-20 | Grant or award · Stock Option (right to buy) | +108,750 | 108,750 | D | ||
Loading xslF345X03/doc4.xml…